Unexplained hypercobalaminemia, particularly levels above 1,000 pg/mL, has been associated with liver disease, kidney dysfunction, myeloproliferative disorders, and certain solid cancers in multiple large-scale studies
However, like all medications, it is important for individuals to consult with one of our Thrive providers to understand the potential benefits and risks, and to determine if Semaglutide is the right option for their specific health needs
Both semaglutide and tirzepatide are GLP-1-based injectable weight loss medications, but tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates an additional hormonal pathway that amplifies metabolic effects
GLP-1 boosters , marketed by ColonBroom, Bioma, HUM, Supergut, and others
TMA, transcription-mediated amplification Table 5
~ AlphaMD The first few months on TRT can feel electric